Drug Class % of Patients
(n=54) (e)
% Eligible for
Discontinuation (f)
Number of Prescriptions
During Enrollment (g)
Number of Prescriptions
Eligible for Discontinuation (h)
GLP-1 (a) 50.00% 85.19% 27 23
DPP-4 (b)(d) 31.48% 82.35% 17 14
SGLT-2 (c)(d) 24.07% 69.23% 13 9
Total NA (i) 83.33% 57 46